Fulton Breakefield Broenniman’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Buy |
814
+18
| +2% | +$7K | 0.02% | 154 |
|
|
2025
Q1 | $346K | Hold |
796
| – | – | 0.03% | 134 |
|
|
2024
Q4 | $294K | Hold |
796
| – | – | 0.02% | 148 |
|
|
2024
Q3 | $414K | Hold |
796
| – | – | 0.03% | 124 |
|
|
2024
Q2 | $431K | Hold |
796
| – | – | 0.03% | 124 |
|
|
2024
Q1 | $413K | Hold |
796
| – | – | 0.03% | 121 |
|
|
2023
Q4 | $375K | Buy |
796
+78
| +11% | +$36.8K | 0.03% | 125 |
|
|
2023
Q3 | $313K | Buy |
718
+3
| +0.4% | +$1.31K | 0.03% | 137 |
|
|
2023
Q2 | $318K | Sell |
715
-3
| -0.4% | -$1.33K | 0.03% | 140 |
|
|
2023
Q1 | $330K | Buy |
718
+3
| +0.4% | +$1.38K | 0.03% | 136 |
|
|
2022
Q4 | $367K | Hold |
715
| – | – | 0.03% | 131 |
|
|
2022
Q3 | $325K | Hold |
715
| – | – | 0.03% | 131 |
|
|
2022
Q2 | $345K | Buy |
+715
| New | +$345K | 0.03% | 132 |
|
|
2022
Q1 | – | Sell |
-711
| Closed | -$330K | – | 176 |
|
|
2021
Q4 | $330K | Hold |
711
| – | – | 0.02% | 164 |
|
|
2021
Q3 | $265K | Hold |
711
| – | – | 0.02% | 158 |
|
|
2021
Q2 | $271K | Hold |
711
| – | – | 0.02% | 162 |
|
|
2021
Q1 | $255K | Hold |
711
| – | – | 0.02% | 160 |
|
|
2020
Q4 | $228K | Buy |
+711
| New | +$228K | 0.03% | 129 |
|
|
2020
Q1 | – | Sell |
-711
| Closed | -$215K | – | 162 |
|
|
2019
Q4 | $215K | Buy |
+711
| New | +$215K | 0.03% | 177 |
|
|
2015
Q2 | – | Sell |
-29,830
| Closed | -$4.61M | – | 124 |
|
|
2015
Q1 | $4.61M | Buy |
29,830
+147
| +0.5% | +$22.7K | 1.03% | 42 |
|
|
2014
Q4 | $3.73M | Buy |
29,683
+218
| +0.7% | +$27.4K | 0.82% | 50 |
|
|
2014
Q3 | $3.53M | Buy |
29,465
+460
| +2% | +$55K | 0.83% | 53 |
|
|
2014
Q2 | $3.12M | Sell |
29,005
-219
| -0.7% | -$23.6K | 0.76% | 53 |
|
|
2014
Q1 | $2.91M | Sell |
29,224
-103
| -0.4% | -$10.3K | 0.75% | 52 |
|
|
2013
Q4 | $2.71M | Sell |
29,327
-600
| -2% | -$55.4K | 0.72% | 55 |
|
|
2013
Q3 | $2.5M | Buy |
29,927
+1,236
| +4% | +$103K | 0.67% | 55 |
|
|
2013
Q2 | $2.35M | Buy |
+28,691
| New | +$2.35M | 0.69% | 55 |
|